Fundraising Fox

Praxis Precision Medicines

NASDAQ: PRAX

Cambridge, US · Founded 2015 · Delaware corporation · 3 known investors

Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.

Biotech

Founders & leadership

NG
Nicholas G. GalakatosDirector
KR
Kiran ReddyExecutive Officer, Director

Investors · 3

OCV PartnersLos Angeles
ClarusreportedCambridge
Vida VenturesreportedLos Angelesvia Stefan Vitorovic · board

Reported raises · per SEC filings

Form D private placements
▶$10MraisedJun 2019 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • KIRAN REDDYExecutive Officer, Director
  • NICHOLAS GALAKATOSDirector
  • THOMAS DYRBERGDirector
  • STEFAN VITOROVICDirector
  • STUART CHAFFEEExecutive Officer
  • WILLIAM YOUNGDirector
  • PAUL MEDEIROSDirector
  • ARI BRETTMANDirector
  • GREGORY NORDENDirector
  • ALFRED SANDROCKDirector
Offering amount
$10M
Amount sold
$10M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.8MraisedMar 2018 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William D. YoungDirector
  • Alfred Sandrock, Jr.Director
  • Nicholas G. GalakatosDirector
  • Stuart ChaffeeExecutive Officer
  • Kiran ReddyExecutive Officer, Director
Offering amount
$46.4M
Amount sold
$18.8M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedNov 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas G. GalakatosDirector
  • Kiran ReddyExecutive Officer, Director
Offering amount
$7.7M
Amount sold
$3.1M
First sale
Oct 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.